Skip to main content

Animations

MJFF Publications

8101 - 8110 of 8587 Results
Title
Year
  • Year
  • 2024
  • 2014
  • 2021
  • 2021
  • 2018
  • 2016
  • 2025
  • 2022
  • 2025
  • 2020
  • Summary Details
    OPEN
    Title: Seeding activity of skin misfolded tau as a biomarker for tauopathies
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00781-1
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Essential Tremor in the Elderly and Risk for Dementia
    Journal Name: Journal of Neurodegenerative Diseases
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2014/328765
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2086
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2005894118
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00435
    Best OA location URL:
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.317
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.70078
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29062
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Network spreading and local biological vulnerability in amyotrophic lateral sclerosis
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-025-08561-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-74195-6
    Citation Count: 36
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.